Lyme Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
March 08, 2021 - Saint-Herblain (France) and New York, NY, March 8, 2021 – Valneva SE (“Valneva”), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. (NYSE: PFE)... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 8, 2021 Category: Pharmaceuticals Source Type: clinical trials

Direct Diagnosis of Disseminated Lyme Borreliosis.
Conditions:   Disseminated Lyme Borreliosis;   Neuroborreliosis;   Lyme Arthritis;   Acrodermatitis Chronica Atrophican Intervention:   Procedure: Targeted proteomics in skin +/- cerebrospinal or synovial fluid to diagnose disseminated Lyme disease Sponsor:   University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Direct Diagnosis of Disseminated Lyme Borreliosis.
Condition:   Lyme Disease Intervention:   Procedure: Targeted proteomics in skin +/- cerebrospinal or synovial fluid to diagnose disseminated Lyme disease Sponsor:   University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials